Key points are not available for this paper at this time.
Ferredoxin 1 (FDX1) plays key roles in promoting elesclomol-induced cuproptosis against cancer, whether it has the potential to be a new therapeutic strategy against glioblastoma has not yet been clarified.
Wu et al. (Thu,) studied this question.